Trademark: 86282220
Status Date
Friday, March 24, 2023
Registration Number
5166752
Registration Date
Tuesday, March 21, 2017
Filing Date
Thursday, May 15, 2014
Published for Opposition
Tuesday, December 15, 2015
41 Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders
5 Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens
42 Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing
CTI BIO PHARMA
"BIOPHARMA"
Mar 24, 2023
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Mar 24, 2023
Case Assigned To Post Registration Paralegal
Sep 13, 2022
Teas Section 8 & 15 Received
Mar 21, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 12, 2020
Review Of Correspondence Complete - Address Updated
May 14, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 14, 2020
Teas Change Of Correspondence Received
May 14, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
May 14, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 14, 2020
Teas Change Of Owner Address Received
May 6, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 6, 2020
Teas Change Of Correspondence Received
May 6, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
May 6, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
May 6, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 6, 2020
Teas Change Of Owner Address Received
Mar 21, 2017
Registered-Principal Register
Feb 16, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 15, 2017
Allowed Principal Register - Sou Accepted
Jan 25, 2017
Teas/Email Correspondence Entered
Jan 25, 2017
Correspondence Received In Law Office
Jan 19, 2017
Teas Response To Office Action Received
Jan 19, 2017
Teas Extension Received
Sep 26, 2016
Notification Of Non-Final Action E-Mailed
Sep 26, 2016
Non-Final Action E-Mailed
Sep 26, 2016
Su - Non-Final Action - Written
Sep 2, 2016
Notice Of Approval Of Extension Request E-Mailed
Sep 1, 2016
Statement Of Use Processing Complete
Aug 8, 2016
Use Amendment Filed
Sep 1, 2016
Sou Extension 1 Granted
Aug 8, 2016
Sou Extension 1 Filed
Aug 31, 2016
Case Assigned To Intent To Use Paralegal
Aug 8, 2016
Teas Extension Received
Aug 8, 2016
Teas Statement Of Use Received
May 6, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
May 6, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 9, 2016
Noa E-Mailed - Sou Required From Applicant
Dec 15, 2015
Official Gazette Publication Confirmation E-Mailed
Dec 15, 2015
Published For Opposition
Nov 25, 2015
Notification Of Notice Of Publication E-Mailed
Nov 6, 2015
Law Office Publication Review Completed
Oct 26, 2015
Approved For Pub - Principal Register
Oct 20, 2015
Teas/Email Correspondence Entered
Oct 19, 2015
Correspondence Received In Law Office
Oct 19, 2015
Teas Request For Reconsideration Received
Apr 29, 2015
Notification Of Final Refusal Emailed
Apr 29, 2015
Final Refusal E-Mailed
Apr 29, 2015
Final Refusal Written
Mar 11, 2015
Teas/Email Correspondence Entered
Mar 11, 2015
Correspondence Received In Law Office
Mar 6, 2015
Assigned To Lie
Feb 26, 2015
Teas Response To Office Action Received
Aug 31, 2014
Notification Of Non-Final Action E-Mailed
Aug 31, 2014
Non-Final Action E-Mailed
Aug 31, 2014
Non-Final Action Written
Aug 31, 2014
Assigned To Examiner
Jul 2, 2014
Automatic Update Of Assignment Of Ownership
May 29, 2014
Notice Of Pseudo Mark E-Mailed
May 28, 2014
New Application Office Supplied Data Entered
May 19, 2014
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
